Benjamin Chevalier
Overview
Explore the profile of Benjamin Chevalier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbry F, Chevalier B, Beron A, Lion G, Boury S, Marciniak C, et al.
J Nucl Med
. 2025 Jan;
66(2):330.
PMID: 39819693
No abstract available.
2.
Chevalier B, Ghander C, Ladsous M, Gaujoux S, Taieb D, Buffet C, et al.
Ann Endocrinol (Paris)
. 2025 Jan;
86(1):101699.
PMID: 39818294
In over 80% of cases, primary hyperparathyroidism results from hypersecretion of PTH by a single parathyroid adenoma. Multi-glandular involvement, combining adenoma and/or hyperplasia in varying proportions, is also possible, although...
3.
Chevalier B, Lion G, Semah F, Huglo D
Ann Endocrinol (Paris)
. 2024 Jun;
85(3):173-174.
PMID: 38871509
No abstract available.
4.
Chevalier B, Bonnet D, Lepage C, Perrier M, Borson-Chazot F, Abeillon J, et al.
J Endocr Soc
. 2024 Jun;
8(7):bvae102.
PMID: 38854908
Background: Vasoactive intestinal peptide (VIP)-secreting tumors (VIPomas) are digestive neuroendocrine tumors in which the hormonal secretion is life-threatening. Biological confirmation is obtained by demonstrating an elevation in plasma VIP, usually...
5.
Chevalier B, Coppin L, Romanet P, Cuny T, Maiza J, Abeillon J, et al.
J Clin Endocrinol Metab
. 2024 Jan;
109(7):e1482-e1493.
PMID: 38288531
Context: Germline CDKN1B variants predispose patients to multiple endocrine neoplasia type 4 (MEN4), a rare MEN1-like syndrome, with <100 reported cases since its discovery in 2006. Although CDKN1B mutations are...
6.
Chevalier B, Bedretdinova D, Pellot-Barakat C, Maitre X, Creze M
J Magn Reson Imaging
. 2023 Dec;
60(3):1037-1048.
PMID: 38100302
Background: MR elastography (MRE) may provide quantitative imaging biomarkers of lumbar back muscles (LBMs), complementing MRI in spinal diseases by assessing muscle mechanical properties. However, reproducibility analyses for MRE of...
7.
Jannin A, Dessein A, Do Cao C, Vantyghem M, Chevalier B, Van Seuningen I, et al.
Front Endocrinol (Lausanne)
. 2023 Nov;
14:1248575.
PMID: 37908747
Introduction: Reprogramming of cellular metabolism is now a hallmark of tumorigenesis. In recent years, research on pancreatic neuroendocrine tumors (pNETs) has focused on genetic and epigenetic modifications and related signaling...
8.
Dupuis H, Chevalier B, Cardot-Bauters C, Jannin A, Do Cao C, Ladsous M, et al.
J Endocr Soc
. 2023 Jul;
7(8):bvad083.
PMID: 37409183
Context: In patients with neurofibromatosis type 1 (NF1), guidelines suggest screening for pheochromocytoma by metanephrine measurement and abdominal imaging, which may lead to the discovery of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)...
9.
Mailliez A, Ternynck C, Jannin A, Lemaitre M, Chevalier B, Le Mapihan K, et al.
Transplant Direct
. 2023 May;
9(6):e1493.
PMID: 37250488
Methods: This retrospective cross-sectional study compared MMSE and cognitive function tests between islet-transplanted T1D patients and nontransplanted T1D controls who were transplant candidates. Patients were excluded if they refused. Results:...
10.
Jannin A, Coppin L, Chevalier B, Maurage C, Odou M, Bauters C
Ann Endocrinol (Paris)
. 2023 May;
84(4):424-426.
PMID: 37169283
No abstract available.